Thursday, 19 December 2019

Gastroparesis Drugs Market Size, Share, Opportunity, Analysis, Growth, Potential and Demand Forecast 2017-2023


KD Market Insights has published a new report titled “Gastroparesis Drugs Market – by Drug Class (Prokinetic Agents, Antiemetic Agents, and Botulinum Toxin Injections), Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, and Post-Surgical Gastroparesis), and End User (Hospitals, Pharmacies, Clinics, and E-commerce) - Global Opportunity Analysis and Industry Forecast, 2017-2023,”.

According to report, the global Gastroparesis Drugs market was valued at around USD $4,667 Million in 2016 and is expected to reach approximately USD $6,486 Million by 2023, growing at a CAGR of around 4.7% between 2017 and 2023.


The market research report provides a thorough analysis of the industry trends, market opportunities, growth drivers which would help the investors to create and align their market strategies according to the current and future market dynamics.

The study is segmented based on By Drug Class, By Disease Type, By End User, and geographical regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Further, the report also analyses key countries such as United States, China, Japan, Germany, United Kingdom, Korea, Brazil, GCC, Africa and Southeast Asia & India.

The report is sub-segmented By Drug Class – Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections. By Disease Type – Diabetic Gastroparesis, Idiopathic Gastroparesis, Post-surgical Gastroparesis, Others. By End User – Hospitals, Pharmacie, Clinics, E-commerce.

Geographically, the report provides an exhaustive analysis of geographical scenario of the market delivers detailed analysis including market size, share, year on year growth and opportunity analysis about the five major geographies including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Further, the regions are segmented into countries:
·        North America (U.S. & Canada)
·        Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
·        Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
·        Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
·        Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Some of major Gastroparesis Drugs marketplayers are – Allergan, Plc., Abbott Laboratories (Abbott Arzneimittel GmbH), AstraZeneca Plc., Cadila Pharmaceuticals Ltd., ETX Pharma, Inc, Evoke Pharma, GlaxoSmithKline Plc., Neurogastrx, Inc., Valeant Pharmaceuticals International, Inc., Theravance Biopharma, among others.

This report provides detailed analysis of the company’s business and financial performance such as net revenue, sales split by segment and by region, SWOT Analysis, company overview, business strategy, product offerings, recent news & development and other major events. The report also analyzes company’s positioning and market share in Gastroparesis Drugs Market.
key features of the market research report include:
·        The report provides a basic overview of the market including its definition, market maturity analysis, porters five force analysis and value chain analysis
·        The report presents market dynamics which includes market drivers and restraints, industry trends, and market opportunities.
·        The report provides market size for 2017, preliminary estimate for 2017 and forecast for 2017-2023.
·        The total market is further divided and analyzed by geographies and countries
·        An all-inclusive data for segment market analysis by market segment on the basis of By Drug Class, By Disease Type, By End User.
·        The report also offers market share of major players, and detailed company profile.


Table Of Content:

CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. TOP PLAYER POSITIONING, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Rise in number of surgeries
3.4.1.2. Increase in the incidence rate of diabetes
3.4.1.3. Growth in geriatric population

3.4.2. Restrains

3.4.2.1. Side effects of gastroparesis drugs
3.4.2.2. Time-consuming regulatory process

3.4.3. Opportunities

3.4.3.1. Presence of untapped market
3.4.3.2. Strong pipeline for gastroparesis drugs

3.4.4. Impact analysis

3.5. CLINICAL TRIALS
3.6. PATENT ANALYSIS

3.6.1. Patent analysis, by year

CHAPTER 4 GASTROPARESIS DRUGS MARKET, BY DRUG CLASS

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PROKINETIC AGENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ANTIEMETIC AGENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. BOTULINUM TOXIN INJECTIONS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 GASTROPARESIS DRUGS MARKET, BY DISEASE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DIABETIC GASTROPARESIS

5.2.1. Market size and forecast

5.3. IDIOPATHIC GASTROPARESIS

5.3.1. Market size and forecast

5.4. POST-SURGICAL GASTROPARESIS

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

CHAPTER 6 GASTROPARESIS DRUGS MARKET, BY DISTRIBUTION CHANNEL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. PHARMACIES

6.3.1. Market size and forecast

6.4. CLINICS

6.4.1. Market size and forecast

6.5. E-COMMERCE

6.5.1. Market size and forecast
Continue:

Get Exclusive Discount on This Report:  https://www.kdmarketinsights.com/discount/5102

About Us:
KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Insights, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 300 companies and leading advisory firms.

Contact Us:
KD Market Insights
30 State Street, Albany,
New York, USA 12203
+1 (317) 300-1217


No comments:

Post a comment